Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease.

Gauthier-Bastien A, Ung RV, Larivière R, Mac-Way F, Lebel M, Agharazii M.

Clin Exp Hypertens. 2014;36(3):173-80. doi: 10.3109/10641963.2013.804541. Epub 2013 Jun 20.

PMID:
23786435
2.

Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.

Larivière R, Gauthier-Bastien A, Ung RV, St-Hilaire J, Mac-Way F, Richard DE, Agharazii M.

J Hypertens. 2017 Feb;35(2):376-384. doi: 10.1097/HJH.0000000000001161.

PMID:
28005706
3.

Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification.

Agharazii M, St-Louis R, Gautier-Bastien A, Ung RV, Mokas S, Larivière R, Richard DE.

Am J Hypertens. 2015 Jun;28(6):746-55. doi: 10.1093/ajh/hpu225. Epub 2014 Nov 27.

PMID:
25430697
4.

Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model.

Ng K, Hildreth CM, Phillips JK, Avolio AP.

Am J Physiol Renal Physiol. 2011 Jun;300(6):F1431-6. doi: 10.1152/ajprenal.00079.2011. Epub 2011 Apr 6.

5.

Angiopoietin-2-induced arterial stiffness in CKD.

Chang FC, Chiang WC, Tsai MH, Chou YH, Pan SY, Chang YT, Yeh PY, Chen YT, Chiang CK, Chen YM, Chu TS, Wu KD, Lin SL.

J Am Soc Nephrol. 2014 Jun;25(6):1198-209. doi: 10.1681/ASN.2013050542. Epub 2014 Feb 7.

6.

Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4.

Ford ML, Tomlinson LA, Smith ER, Rajkumar C, Holt SG.

Nephrol Dial Transplant. 2010 Jun;25(6):1853-8. doi: 10.1093/ndt/gfp723. Epub 2010 Jan 14.

PMID:
20075438
7.

Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension.

Ameer OZ, Salman IM, Avolio AP, Phillips JK, Butlin M.

Am J Physiol Heart Circ Physiol. 2014 Jul 15;307(2):H143-51. doi: 10.1152/ajpheart.00139.2014. Epub 2014 May 16.

8.

4D.07: ENDOTHELIN A RECEPTOR BLOCKADE REDUCES VASCULAR CALCIFICATION IN RATS WITH CHRONIC KIDNEY DISEASE AND MINERAL DISORDERS.

Agharazii M, Gauthier-Bastien A, Ung RV, Mac-Way F, Richard D, Lariviere R.

J Hypertens. 2015 Jun;33 Suppl 1:e62. doi: 10.1097/01.hjh.0000467511.21263.68.

PMID:
26102877
9.

Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats.

Kumata C, Mizobuchi M, Ogata H, Koiwa F, Kondo F, Kinugasa E, Akizawa T.

Ther Apher Dial. 2011 Jun;15 Suppl 1:18-22. doi: 10.1111/j.1744-9987.2011.00921.x.

PMID:
21595847
10.

Relationship between aortic pulse wave velocity, selected proinflammatory cytokines, and vascular calcification parameters in peritoneal dialysis patients.

Krzanowski M, Janda K, Dumnicka P, Dubiel M, Stompór M, Kuśnierz-Cabala B, Grodzicki T, Sułowicz W.

J Hypertens. 2014 Jan;32(1):142-8. doi: 10.1097/HJH.0b013e32836569c7.

PMID:
24309487
11.

Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.

Noonan W, Koch K, Nakane M, Ma J, Dixon D, Bolin A, Reinhart G.

Nephrol Dial Transplant. 2008 Dec;23(12):3824-30. doi: 10.1093/ndt/gfn375. Epub 2008 Jul 20.

PMID:
18644798
12.

Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.

Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, Steppan S, Volsek M, Kribben A, Nierhaus M, Jankowski V, Zidek W, Jankowski J.

Am J Nephrol. 2012;35(1):31-9. doi: 10.1159/000334742. Epub 2011 Dec 15.

PMID:
22179063
13.

A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.

Kitagawa M, Sugiyama H, Morinaga H, Inoue T, Takiue K, Ogawa A, Yamanari T, Kikumoto Y, Uchida HA, Kitamura S, Maeshima Y, Nakamura K, Ito H, Makino H.

PLoS One. 2013;8(2):e56695. doi: 10.1371/journal.pone.0056695. Epub 2013 Feb 19.

14.

Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.

Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG.

Nephrol Dial Transplant. 2008 Feb;23(2):586-93. Epub 2007 Oct 12.

PMID:
17933842
15.

Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.

Thamratnopkoon S, Susantitaphong P, Tumkosit M, Katavetin P, Tiranathanagul K, Praditpornsilpa K, Eiam-Ong S.

Nephron. 2017;135(3):167-172. doi: 10.1159/000453368. Epub 2016 Dec 13.

PMID:
27951533
16.

Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.

Chan DT, Watts GF, Irish AB, Ooi EM, Dogra GK.

Am J Hypertens. 2013 Sep;26(9):1155-61. doi: 10.1093/ajh/hpt077. Epub 2013 Jun 4.

PMID:
23736110
17.

Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease.

Kramann R, Kunter U, Brandenburg VM, Leisten I, Ehling J, Klinkhammer BM, Knüchel R, Floege J, Schneider RK.

J Bone Miner Res. 2013 Dec;28(12):2523-34. doi: 10.1002/jbmr.1994.

18.

Vitamin D affects survival independently of vascular calcification in chronic kidney disease.

Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, Choukroun G, Fournier A, Massy ZA.

Clin J Am Soc Nephrol. 2009 Jun;4(6):1128-35. doi: 10.2215/CJN.00260109. Epub 2009 May 14.

19.

[The histological changes in radial artery in uremia and their effects on arterial stiffness].

Yan TK, Lin S, Jia JY, Li YP, Shang WY, Wei L.

Zhonghua Nei Ke Za Zhi. 2010 Jul;49(7):577-81. Chinese.

PMID:
20979767
20.

Vascular calcification and arterial stiffness in chronic kidney disease: implications and management.

Toussaint ND, Kerr PG.

Nephrology (Carlton). 2007 Oct;12(5):500-9. Review.

PMID:
17803475

Supplemental Content

Support Center